Cue Biopharma Inc Operating margin
What is the Operating margin of Cue Biopharma Inc?
The Operating margin of Cue Biopharma Inc is -582.23%
What is the definition of Operating margin?
Operating margin is the ratio of operating income divided by net sales and presented in percent.
ttm (trailing twelve months)
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Operating margin of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc
What does Cue Biopharma Inc do?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Companies with operating margin similar to Cue Biopharma Inc
- Ionic Rare Earths has Operating margin of -590.35%
- ATIF has Operating margin of -589.20%
- DermTech has Operating margin of -588.62%
- Dyadic International has Operating margin of -585.39%
- Dyadic International has Operating margin of -585.39%
- Cardax has Operating margin of -584.76%
- Cue Biopharma Inc has Operating margin of -582.23%
- Avalon GloboCare has Operating margin of -581.69%
- Avalon GloboCare has Operating margin of -581.69%
- Avalon GloboCare has Operating margin of -581.69%
- Avalon GloboCare has Operating margin of -581.69%
- Avalon GloboCare has Operating margin of -581.69%
- Avalon GloboCare has Operating margin of -581.69%